Book a demo

Epoxy Resin Scale-Up Patents: Leaders, Trends & White Space 2026

Epoxy Resin Scale-Up Patents: Leaders, Trends & White Space 2026
https://www.patsnap.com/resources/blog/rd-blog/epoxy-resin-scale-up-and-mass-production-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Patent Landscape · Polymers & Composites
Epoxy Resin Scale-Up and Mass Production Patents
  • Filing peaked in 2018 and has not recovered: the yearly count has trailed off toward zero, suggesting the core process claims for continuous polymerization and reactive extrusion were staked out early and the field has cooled rather than accelerated.
  • Condensation chemistry dominates the claim space: all 126 families sit under C08G, with C08L compositions layered on top of three-quarters of them — additive and formulation claims, not the base reaction, are where most of the recent activity concentrates.
  • Co-filing is rare and clustered: only nine co-assignee pairs exist across the whole set, and the strongest ones are supplier-partner pairings rather than broad industry consortia, which points to isolated bilateral R&D rather than shared standards work.
Get a prior-art report on your approach
126
Published Records
45%
Top-5 Share of All Records
+100%
Filing Growth 2021→2024
EP
Leading Jurisdiction

Filing growth compares 2021 (1 records) with 2024 (2) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 126 records in scope (CR5), not by the ranked leaders only.

Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Overview

What this landscape covers

This dataset tracks patent families at the intersection of epoxy resin chemistry and process scale-up — continuous polymerization, reactive extrusion, and resin manufacturing scale-up specifically, rather than epoxy formulation in general. The search restricts to records whose title, abstract or claims name both an epoxy resin term and a scale-up process term, filtered to the IPC classes covering condensation polymer reactions and chemical/physical process apparatus. That combination narrows a very large parent field (epoxy chemistry) down to the subset of filings that actually address how the material is made at volume, not just what it is made of.

Coverage runs from 2015 through the 2026 cut-off, with 126 published families in total. Because publication typically lags filing by around 18 months, the most recent one to two years in any trend line will understate real filing activity — treat the tail of the chart as a floor, not a ceiling.

Filing activity, 2017–2026
  1. 1BASF CORPORATON19
  2. 2KANEKA CORP11
  3. 3DOW GLOBAL TECHNOLOGIES LLC10
  4. 4CLARIANT INT LTD9
  5. 5SABIC INNOVATIVE PLASTICS IP BV8
  6. 6GENERAL ELECTRIC CO7
  7. 7TORAY INDUSTRIES INC7
  8. 8JOHNSON POLYMER LLC6
  9. 9MITSUI CHEMICALS INC5
  10. 10SUMITOMO KAGAKU KOGYO KK5
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Epoxy Resin Scale-Up and Mass Production covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The numbers

Filing trend and technology composition

Two views of the same 126 families: when the claims were filed, and which IPC subclasses they were filed under. Read together they show a field that staked its ground early and has since layered formulation and coating claims on top of a fixed reaction core.

A single peak, then decline

Annual filings rose to a peak of 6 in 2018 and have fallen since, with the midpoint year of the window showing no filings at all. That shape is consistent with a technology whose core process claims were established in the mid-2010s and have not needed re-filing — new entrants would be building on, or around, a settled base rather than opening new ground.

A single peak, then decline023564201762018201920202021202220232024202502026Most recent year is partial — publication lag means later filings are not yet visible.

Condensation chemistry with formulation layered on top

Every family in the set carries a C08G condensation-polymer classification, and 75 of the 126 also carry C08L (polymer compositions) — meaning most filings pair a process claim with a formulation claim. Smaller but consistent counts in C09D (coatings), C08K (additives) and C09J (adhesives) show where the resin ends up being applied, while H05K (printed circuits) marks a narrower electronics-packaging use case.

Condensation chemistry with formulation layered on topC08G · Condensation polymers126100.0%C08L · Polymer compositions7559.5%C08F · Addition polymers (vinyl etc.)3729.4%C09D · Coatings, paints & inks3124.6%C08K · Use of additives in polymers2923.0%C09J · Adhesives2116.7%B32B · Layered products & laminates1511.9%H05K · Printed circuits & assemblies1511.9%Other4233.3%

Shares are the percentage of the 126 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Epoxy Resin Scale-Up and Mass Production covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Epoxy Resin Scale-Up and Mass Production with Eureka

This page is one run against one query. Ask Eureka your own question about epoxy resin scale-up and mass production and every answer comes back with the patent numbers behind it.

Try Eureka
Key patents

The records anchoring this space

Representative filing
US6770691B22004-08-03

US6770691B2 — Curable epoxy resin compositions and the cured residues thereof

SABIC INNOVATIVE PLASTICS IP B.V.

A cured composition is the cured residue of a curable composition including (a) an epoxy resin essentially free of bromine atoms, a curing agent for the epoxy resin, (b) a flame retardant additive that is the condensation product of (i) a brominated phenol or a mixture of brominated phenols with (ii) a cyanuric halide; and (c) a thermoplastic resin. The preferred epoxy resin is a mixture of an epoxy resin with less than 2 glycidyl ether groups per molecule and an epoxy resin that has greater than 2 glycidyl ether groups per molecule.Filed by SABIC Innovative Plastics IP B.V., granted 2004-08-03 — a bromine-free flame-retardant epoxy composition that predates the current scale-up filing cluster by over a decade.

US6770691B2 — patent drawing 1US6770691B2 — patent drawing 2
View full record
Most-cited records in the corpus
#Publication no.Patent titleCitations
1US5962093AThermally stable polyetheramines190
2WO2003066704A1Oligomeric chain extenders for processing, post−processing and recycling of condensation polymers, synthesis,…189
3US20070052131A1Method of producing a weld-cut sealing/heat-shrinkable packaging film formed of a polyethylene terephthalate-…57
4US20090192265A1Curable composition32
5JP2004155176APolyethylene terephthalate polyester melt bonding film and its manufacturing process31
6CN103205224A一种丙烯酸酯乳液复膜胶及其制备方法和应用28
7EP0921158A2Poly(phenylene ether) thermoset compositions28
8US6387990B1Curable epoxy resin compositions with brominated triazine flame retardants25
9US5965673AEpoxy-terminated prepolymer of polyepoxide and diamine with curing agent25
10US5198497APolyolefin, rubber and eva-maleic anhydride terpolymer blend25

Citation counts favour older filings simply because they have had more time to be cited — read this as a map of technical influence, not of current commercial relevance.

Patent titles are shown in the language they were filed in, not translated, so that each record stays verifiable against the original filing — a translated title will not match in Eureka or in any national register. Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Epoxy Resin Scale-Up and Mass Production covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis

 
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the data implies for a filing or freedom-to-operate decision

Three read-throughs from the trend and composition data, aimed at the questions a technical or IP lead actually has to answer before committing R&D budget.

Filing momentum
2018 peak, near-zero by 2026
families per year

The rush is over, not the field

A single peak followed by decline usually means the obvious process configurations are claimed and defensible, and remaining filers are picking off narrower formulation or additive variants rather than the base reaction.

Trend across 2017–2026
Claim layering
75 of 126 also in C08L
share carrying a formulation claim

Process and formulation claims travel together

Most applicants are not filing a bare process claim; they pair continuous polymerization or reactive extrusion steps with a specific composition, which narrows what a competitor can design around without also avoiding the composition claim.

IPC co-occurrence
Collaboration density
9 co-assignee pairs
across 126 families

R&D is bilateral, not consortium-driven

The strongest co-filing pairs look like supplier-customer or corporate-affiliate relationships rather than industry-wide standards efforts, so licensing conversations in this space are likely to be one-to-one.

Co-assignee analysis
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to epoxy resin scale-up and mass production, with the prior art for and against each one.

Find the white space →
Strongest co-assignee pairs
AssigneeCo-assigneeShared families
Clariant International Ltd.BASF SE5
Sumitomo Chemical Co., Ltd.Sumitomo Chemical Industries, Ltd.5
Johnson Polymer, Inc.Clariant International Ltd.4
Johnson Polymer, Inc.Johnson Polymer, Inc.2
Dow Global Technologies LLCTHIBAULT RAYMOND J1
Dow Global Technologies LLCOCCHIELLO ERNESTO1
Dow Global Technologies LLCBECKERDITE JOHN1
Dow Global Technologies LLCAGUIRRE VARGAS FABIO1

Pairings cluster around a small number of repeat partnerships rather than a broad network — useful context if you are scouting for a licensing counterpart rather than a standards body.

Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Epoxy Resin Scale-Up and Mass Production covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players

Who holds the ground, and where it is still open

The assignee ranking (rendered separately) sits on top of a filing base that has gone quiet across every named party in the most recent year — a sign the leading holders are maintaining existing positions rather than actively expanding them.

Momentum check
0 filings in latest year
for every top assignee tracked

No one is currently pushing forward

Every assignee with recent-year momentum data shows zero filings in the latest tracked year, consistent with the overall post-2018 decline. That flat signal across multiple named holders — rather than one laggard — suggests the slowdown is field-wide, not company-specific.

Recent-year momentum
Receiving offices
EPO 35, US 32, JP 16
top three offices by filings

Europe and the US lead filing venues

Europe and the United States between them account for the bulk of receiving-office activity, with Japan a clear third. Canada, WIPO/PCT and Austria trail well behind, indicating most applicants are protecting home or primary-export markets rather than filing broadly.

Receiving office split
Partnership pattern
Strongest pair: 5 shared families
co-assignee overlap

A few repeat partnerships anchor the network

The densest co-assignee relationships involve the same handful of organisations appearing together across five shared families each, rather than a wide web of one-off collaborations — a small, stable set of working relationships rather than an open ecosystem.

Co-assignee pairs
🔍
Under-claimed sub-areas worth a closer look
Branches with process or composition detail thinner than the core C08G/C08L cluster — worth a freedom-to-operate check before assuming they're occupied.
continuous reactive extrusion control loopsin-line viscosity monitoring for scale-upprinted-circuit-grade epoxy processing (H05K overlap)adhesive-grade continuous cure formulationslaminate-specific process scale-up (B32B overlap)
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
Johnson Polymer, Inc.0
General Electric Company0
Clariant International Ltd.0
Dow Global Technologies LLC0
Toray Industries, Inc.0
The Dow Chemical Company0
Kaneka Corporation0
BASF SE0
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Epoxy Resin Scale-Up and Mass Production covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's next

Where to take this

The trend and composition data point to a narrow set of next questions, depending on whether you're scoping a filing, a freedom-to-operate review, or a partner search.

Check freedom-to-operate on formulation variants

Since most families pair a process claim with a C08L composition claim, a new filing needs to clear both layers — not just show a novel process step.

Run a freedom-to-operate check in Eureka

Map the quiet leaders before they refile

Zero recent-year filings across the top assignees doesn't mean abandonment; it may mean a refresh is due. Watching for renewed activity early gives more response time.

Set up assignee monitoring in Eureka

Scope the under-claimed branches

Thin coverage in electronics-packaging and laminate-specific process claims suggests room to file narrowly and defensibly rather than contest the dense C08G core.

Explore white space in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Epoxy Resin Scale-Up and Mass Production covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions about epoxy resin scale-up patents

Answers are grounded in the same dataset. Derived from a Patsnap search on Epoxy Resin Scale-Up and Mass Production covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Epoxy Resin Scale-Up and Mass Production in depth with Eureka

Go past this page: query the whole epoxy resin scale-up and mass production corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.